Depreciation, Depletion and Amortization of OptimizeRx Corp from 31 Dec 2021 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
OptimizeRx Corp quarterly and annual Depreciation, Depletion and Amortization in USD history and change rate from 31 Dec 2021 to 31 Mar 2024.
  • OptimizeRx Corp Depreciation, Depletion and Amortization for the quarter ending 31 Mar 2024 was $1,067,000, a 130% increase year-over-year.
  • OptimizeRx Corp annual Depreciation, Depletion and Amortization for 2023 was $2,401,628, a 19% increase from 2022.
  • OptimizeRx Corp annual Depreciation, Depletion and Amortization for 2022 was $2,022,029, a 2.9% increase from 2021.
Source SEC data
View on sec.gov
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Change (%)
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Change (%)

OptimizeRx Corp Quarterly Depreciation, Depletion and Amortization (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $1,067,000 +$603,000 +130% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q1 2023 $464,000 -$7,540 -1.6% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q1 2022 $471,540 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023 2023 Q1

OptimizeRx Corp Annual Depreciation, Depletion and Amortization (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $2,401,628 +$379,599 +19% 01 Jan 2023 31 Dec 2023 10-K 15 Apr 2024 2023 FY
2022 $2,022,029 +$56,704 +2.9% 01 Jan 2022 31 Dec 2022 10-K 15 Apr 2024 2023 FY
2021 $1,965,325 01 Jan 2021 31 Dec 2021 10-K 10 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.